These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 507561)

  • 21. Primary angiosarcoma of the breast: do enlarged axillary nodes matter?
    Losanoff JE; Jaber S; Esuba M; Perry M; Sauter ER
    Breast J; 2006; 12(4):371-4. PubMed ID: 16848851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glandular structures in an intraoperative axillary sentinel lymph node biopsy: a diagnostic dilemma.
    Nga ME; Putti TC
    Histopathology; 2006 Mar; 48(4):475-7. PubMed ID: 16487377
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of axillary lymph node metastasis in breast cancer].
    Takeuchi S; Yoshida M
    Saishin Igaku; 1968 Mar; 23(3):671-80. PubMed ID: 5684923
    [No Abstract]   [Full Text] [Related]  

  • 24. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
    Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modified radical mastectomy and lymphocyte subsets of regional lymph nodes].
    Nakajima Y; Akimoto M; Kimura M; Sawano A; Iwasaki H; Abe R; Kasai M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2182-6. PubMed ID: 3717962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of carcinoma of the breast by modified radical mastectomy.
    Papatestas AE; Lesnick GJ
    Surg Gynecol Obstet; 1975 Jan; 140(1):22-6. PubMed ID: 1209469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary carcinoma of the breast without axillary lymph node metastases.
    Fracchia AA; Rosen PP; Ashikari R
    Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgery.
    Rampaul RS; Dale OT; Mitchell M; Blamey RW; Macmillan RD; Robertson JF; Ellis IO
    Breast; 2008 Apr; 17(2):195-8. PubMed ID: 18164619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
    Naik R; Baliga P; Bansal R; Pai M
    J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biopsy of the axillary nodes in the surgical treatment of breast carcinoma].
    van Vuuren ZC
    Ned Tijdschr Geneeskd; 1979 Jun; 123(23):958-60. PubMed ID: 460447
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
    Christensen SB; Jansson C
    Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary nodal metastasis of occult breast primary cancer.
    Tamiolakis D; Antoniou C
    Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axillary lymphadenectomy for intraductal carcinoma of the breast.
    Silverstein MJ; Gierson ED; Colburn WJ; Rosser RJ; Waisman JR; Gamagami P
    Surg Gynecol Obstet; 1991 Mar; 172(3):211-4. PubMed ID: 1847243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
    Dale PS; Williams JT
    Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.